Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Long Acting GnRH Antagonist Degarelix in Women With Endometriosis Recurrence

NCT01712763 is registered in ClinicalTrials.gov with Centre for Endocrinology and Reproductive Medicine, Italy as lead sponsor.

NCT NCT01712763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01712763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Long Acting GnRH Antagonist Degarelix in Women With Endometriosis Recurrence
Lead sponsor
Centre for Endocrinology and Reproductive Medicine, Italy
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2012
Completion date
March 31, 2016
Enrollment
360 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis